Fas receptors were constitutively expressed and were not significantly modulated by the treatment with sFasL on neutrophils from healthy subjects, while in T2DM patients the percentage of Fas expressing cells was lower after the induction (P<0.05) (Fig 3C). The gene discussed is FASLG; the disease is type 2 diabetes mellitus.